KROS CapEx to Revenue
Keros Therapeutics Inc · CapEx to Revenue
KROS CapEx to Revenue
Current (TTM)3.29%retrieved
KROS CapEx/Revenue (2.17% → 3.29%)
Latest values, visible window
High-resolution chart · PNG
KROS capex to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | CapEx to Revenue |
|---|---|
| 0.6355% | |
| 54.3944% | |
| 1,631.7881% | |
| 0% | |
| 5.0945% | |
| 0% | |
| 2.71% | |
| 2.17% |